IQV(IQVIA Holdings Inc.) 的财务报表:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $13.87B | $14.41B | $14.98B | $15.40B | $16.31B |
| 毛利润 | — | — | — | — | — |
| 营业利润 | $1.39B | $1.80B | $1.98B | $2.20B | $2.18B |
| 净利润 | $966.00M | $1.09B | $1.36B | $1.37B | $1.36B |
| 经营现金流 | $2.94B | $2.26B | $2.15B | $2.72B | $2.65B |
| 自由现金流 | $2.30B | $1.59B | $1.50B | $2.11B | $2.05B |
| 摊薄每股收益 | $4.95 | $5.72 | $7.29 | $7.49 | $7.84 |